Pim2 cooperates with PML-RAR alpha to induce acute myeloid leukemia in a bone marrow transplantation model

S Agrawal-Singh, S Koschmieder, S Gelsing, C Stocking, M Stehling, C Thiede, NH Thoennissen, G Kohler, Peter Valk, Ruud Delwel, K Mills, N Baumer, L Tickenbrock, K Hansen, WE Berdel, C Muller-Tidow, H Serve

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)


Although the potential role of Pim2 as a cooperative oncogene has been well described in lymphoma, its role in leukemia has remained largely unexplored. Here we show that high expression of Pim2 is observed in patients with acute promyelocytic leukemia (APL). To further characterize the cooperative role of Pim2 with promyelocytic leukemia/retinoic acid receptor alpha (PML/RAR alpha), we used a well-established PML-RAR alpha (PR alpha) mouse model. Pim2 coexpression in PR alpha-positive hematopoietic progenitor cells (HPCs) induces leukemia in recipient mice after a short latency. Pim2-PR alpha cells were able to repopulate mice in serial transplantations and to induce disease in all recipients. Neither Pim2 nor PR alpha alone was sufficient to induce leukemia upon transplantation in this model. The disease induced by Pim2 overexpression in PR alpha cells contained a slightly higher fraction of immature myeloid cells, compared with the previously described APL disease induced by PR alpha. However, it also clearly resembled an APL-like phenotype and showed signs of differentiation upon all-trans retinoic acid (ATRA) treatment in vitro. These results support the hypothesis that Pim2, which is also a known target of Flt3-ITD (another gene that cooperates with PML-RAR alpha), cooperates with PR alpha to induce APL-like disease. (Blood. 2010; 115(22): 4507-4516)
Original languageUndefined/Unknown
Pages (from-to)4507-4516
Number of pages10
Issue number22
Publication statusPublished - 2010

Research programs

  • EMC MM-02-41-03

Cite this